What condition does bladder hydrodistension treat?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Bladder Hydrodistension Treats Bladder Pain Syndrome (Interstitial Cystitis)

Bladder hydrodistension is used to treat Bladder Pain Syndrome (BPS), also known as interstitial cystitis, and should be considered after conservative and oral treatments have failed. 1

What is Bladder Pain Syndrome?

BPS is a chronic condition characterized by pelvic pain, pressure, or discomfort related to the bladder, lasting at least 6 weeks to 6 months, accompanied by urinary symptoms like urgency and frequency, in the absence of infection or other identifiable causes. 1 The condition significantly impacts quality of life, causing low self-esteem, sexual dysfunction, and reduced daily functioning. 1

Role of Hydrodistension in Treatment

Positioning in Treatment Algorithm

Hydrodistension is positioned as a third-line or further treatment option in the BPS management hierarchy: 1, 2

  1. First-line: Conservative measures (dietary modification avoiding caffeine/alcohol/acidic foods, stress management, analgesia, physical therapy)
  2. Second-line: Oral medications (amitriptyline, cimetidine) and intravesical treatments (lidocaine, hyaluronic acid, botulinum toxin A, DMSO, heparin)
  3. Third-line and beyond: Cystoscopy with or without hydrodistension, after referral to pain clinic and multidisciplinary team discussion

Dual Purpose of the Procedure

Hydrodistension serves both diagnostic and therapeutic functions: 2

  • Diagnostic: Identifies Hunner lesions (which appear as reddish, well-demarcated mucosal lesions that bleed), determines anatomic bladder capacity, and assesses for bladder fibrosis
  • Therapeutic: Provides temporary symptom relief in some patients

Important Safety Considerations

High-pressure, long-duration hydrodistension (>80-100 cm water pressure for >10 minutes) is NOT recommended due to serious risks including bladder rupture and sepsis. 1 The evidence shows efficacy rates of only 22-67% with documented cases of bladder rupture in observational studies. 1

Low-pressure hydrodistension is the safer approach. 1 Recent research suggests that 2-minute distension at lower pressures provides optimal clinical effectiveness—longer durations (4-6 minutes) show no additional benefit, while 1-minute duration is insufficient. 3 A 2018 study of 71 women found 55% effectiveness at 2 minutes versus only 20% at 1 minute, with no significant improvement beyond 2 minutes. 3

Clinical Effectiveness

The evidence on hydrodistension effectiveness is mixed:

  • Short-term relief: Some patients experience temporary symptom improvement, though symptoms typically recur within 6 months in the majority of cases. 1
  • Variable response rates: Studies show 32-67% of patients achieve symptomatic improvement. 4
  • No long-term bladder damage: Importantly, multiple hydrodistensions over several years do not result in significant changes in bladder capacity, addressing concerns about repeated procedures. 5 A study of 168 patients undergoing 637 procedures found no significant decrease in bladder capacity over time.

When Hunner Lesions Are Present

If Hunner lesions are identified during cystoscopy, fulguration with laser or electrocautery and/or triamcinolone injection should be performed rather than relying on hydrodistension alone. 1, 2 These lesions do not respond to oral treatments and require direct surgical management. Two observational studies showed 88% symptomatic relief within 2-3 days of laser treatment, though 45% required additional treatment within 23 months. 1

Combination Therapy

Recent evidence suggests combining hydrodistension with onabotulinumtoxin A (100 units submucosal injection in trigone) may provide better results in refractory cases. 6 A 2016 prospective study of 25 patients showed 84% subjective improvement with median duration of 7 months, though this approach requires specialized expertise.

Key Clinical Pitfalls

  • Avoid using hydrodistension as a first-line treatment—it should only be considered after conservative and oral therapies have failed
  • Never perform high-pressure, long-duration distension—the risks far outweigh any potential benefits
  • Don't rely on glomerulations alone for diagnosis—these can appear in asymptomatic patients and are induced by the hydrodistension procedure itself 7
  • Recognize that hydrodistension provides temporary relief—most patients experience symptom recurrence and may require repeat procedures or alternative treatments
  • Ensure multidisciplinary team involvement—patients should be referred to pain clinics and specialists before proceeding with hydrodistension 1

References

1
Guideline

management of bladder pain syndrome: green-top guideline no. 70.

BJOG : an international journal of obstetrics and gynaecology, 2017

Related Questions

What is cystoscopy with hydrodistension and how does it benefit patients with interstitial cystitis/bladder pain syndrome?
A 10‑day postpartum woman presents with dysuria and a urine culture growing mixed microbiota >100,000 CFU/mL; how should this be managed?
What is the appropriate 10‑day antibiotic regimen for a patient undergoing ENT follow‑up after image‑guided fine‑needle aspiration/biopsy, assuming no documented β‑lactam allergy?
In a 10‑month‑old infant with a slightly indented coronal suture, normal fontanelles, and appropriate head growth, what is the appropriate next step in management?
What is the minimum recommended duration of antimicrobial therapy for a deep puncture wound?
What is the recommended second‑line regimen for a patient with Helicobacter pylori infection who cannot take penicillin or metronidazole and has not previously received levofloxacin?
Can MiraLAX (polyethylene glycol 3350) be administered 17 g every 12 hours?
In a patient with Mycoplasma pneumonia receiving antibiotics who after three days develops abdominal pain, jaundice, and laboratory evidence of hemolysis with normal hemoglobin and thrombocytopenia, what is the most appropriate management?
What are the typical cerebrospinal fluid findings in central nervous system toxoplasmosis?
As an occupational medicine specialist, what are the recommended steps to evaluate a repetitive‑strain injury of the upper limb caused by handling chicken bones (indirect work exposure) for capacity reduction and to justify paraffin therapy according to Brazilian occupational disease jurisprudence?
What are the benefits and rationale for using drainage‑only percutaneous nephrostomy as initial management in an adult with an infected complete staghorn calculus presenting with sepsis and impaired renal function?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.